Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Pediatric Neurology Briefs
|
December 7, 2020
Epilepsy and TSC-Associated Neuropsychiatric Disorders
Jamie K Capal
Developmental Medicine and Child Neurology
|
May 28, 2022
Describing autism spectrum disorder in tuberous sclerosis complex: Challenges and future opportunities
Jamie K Capal
Epilepsy & Behavior : E&B
|
November 27, 2020
Genetic testing in patients with nonsyndromic autism spectrum disorder and EEG abnormalities with or without epilepsy: Is exome trio-based testing the best clinical approach?
Amelle Shillington, Jamie K Capal
Pediatric Clinics of North America
|
February 29, 2024
Autism and Epilepsy
Jamie K Capal, Shafali S Jeste
Neuropsychiatric Disease and Treatment
|
September 8, 2016
Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy
Jamie K Capal, David Neal Franz
Orphanet Journal of Rare Diseases
|
March 15, 2017
mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders
David N Franz, Jamie K Capal
Frontiers in Psychiatry
|
May 29, 2026
Editorial: Psychiatric insights in genetic and chromosomal disorders
Hiroki Ishiguro, Itaru Kushima, Jamie K Capal
Pediatrics
|
April 3, 2020
Factors Associated With Seizure Onset in Children With Autism Spectrum Disorder
Jamie K Capal, Eric A Macklin, Frances Lu, et al.
Epilepsy & Behavior : E&B
|
October 21, 2018
EEG endophenotypes in autism spectrum disorder
Jamie K Capal, Christopher Carosella, Elora Corbin, et al.
Pediatric Neurology
|
May 7, 2021
Diabetes in Individuals With Tuberous Sclerosis Complex Treated With mTOR Inhibitors
Karen Agricola, Gabrielle Stires, Darcy A Krueger, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Pediatric Neurology Briefs
|
December 7, 2020
Epilepsy and TSC-Associated Neuropsychiatric Disorders
Jamie K Capal
Developmental Medicine and Child Neurology
|
May 28, 2022
Describing autism spectrum disorder in tuberous sclerosis complex: Challenges and future opportunities
Jamie K Capal
Epilepsy & Behavior : E&B
|
November 27, 2020
Genetic testing in patients with nonsyndromic autism spectrum disorder and EEG abnormalities with or without epilepsy: Is exome trio-based testing the best clinical approach?
Amelle Shillington, Jamie K Capal
Pediatric Clinics of North America
|
February 29, 2024
Autism and Epilepsy
Jamie K Capal, Shafali S Jeste
Neuropsychiatric Disease and Treatment
|
September 8, 2016
Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy
Jamie K Capal, David Neal Franz
Orphanet Journal of Rare Diseases
|
March 15, 2017
mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders
David N Franz, Jamie K Capal
Frontiers in Psychiatry
|
May 29, 2026
Editorial: Psychiatric insights in genetic and chromosomal disorders
Hiroki Ishiguro, Itaru Kushima, Jamie K Capal
Pediatrics
|
April 3, 2020
Factors Associated With Seizure Onset in Children With Autism Spectrum Disorder
Jamie K Capal, Eric A Macklin, Frances Lu, et al.
Epilepsy & Behavior : E&B
|
October 21, 2018
EEG endophenotypes in autism spectrum disorder
Jamie K Capal, Christopher Carosella, Elora Corbin, et al.
Pediatric Neurology
|
May 7, 2021
Diabetes in Individuals With Tuberous Sclerosis Complex Treated With mTOR Inhibitors
Karen Agricola, Gabrielle Stires, Darcy A Krueger, et al.
Page
of 4